About Us

Ibis is defining the future of precision by guiding drugs toward beneficial on-targets and away from harmful off-targets. Its AI-driven Molecular Fingerprint™  Platform engine enables valuable insights into information about drug candidates with the potential for maximum efficacy and safety. Transcending the one disease-one target-one drug paradigm allows the Ibis platform to integrate polypharmacology, selectivity profiling, safety assessments, and drug repurposing into a coherent framework applicable to all stages of drug discovery and development.